- About Us
- Healthcare Companies
- Pharmacy Solutions
- Healthcare Professionals
- Contact Us
- MyAH Portal
Class 4 Caution in Use
Pfizer Limited have informed the MHRA that an outdated version of the Patient Information Leaflet (PIL) has been included in the packaging of the above mentioned batches of Depo-Medrone with Lidocaine (Methylprednisolone acetate and Lidocaine hydrochloride) 40 mg/mL 1 mL and 2 mL vials (single vial presentations) to the UK market.
MHRA drug alert link:
DEPO MEDRONE LIDOCAIN 40MG/ML, 1ML
DEPO MEDRONE LIDOCAIN 40MG/ML, 2ML
This is a caution in use only we are not accepting stock returns.
If you have any questions, please contact Pfizer Medical Information Department on 01304 616161